共 29 条
[11]
Schulman CC(2000)4-Year follow up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy Eur Urol 38 706-713
[12]
Van Popel H(1995)Neoadjuvant hormone therapy before radical prostatectomy decrease the number of positivemargins in stage T2 prostate cancer: interim results of a prospective randomized trial J Urol 154 429-434
[13]
Powell IJ(2002)Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year follow-up, Phase II Southwest Oncology Group Study 9109 J Urol 168 2016-2019
[14]
Pilepech MV(1997)Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Protocol 85-31 J Clin Oncol 15 1013-1021
[15]
Lawton CA(2001)Updated results of the phase III radiation therapy oncology group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate Int J Radiat Oncol Biol Phys 49 937-946
[16]
Klotz L(2000)Neoadjuvant hormone therapy: the Canadian trials Mol Urol 4 233-238
[17]
Mazhar D(2006)Improving outcomes in early prostate cancer: part I—adjuvant treatment BJU Int 98 725-730
[18]
Pettaway CA(2000)Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results J Clin Onc 18 1050-1057
[19]
Clark PE(2001)Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer Urology 57 281-285
[20]
Oh WK(2001)Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: a preliminary report Semin Oncol 28 S40-S44